Objective
Pharmaceutically active compounds (PhACs) are a special class of contaminants because they can undergo transformations through metabolism before their entrance into aquatic and terrestrial environments. Once they reach the environment they are further transformed by abiotic and/or biotic transformation processes and understanding of transformation pathways and identification of transformation products (TP) is a prerequisite for a thorough assessment of their environmental risk. This project proposes the use of Experimental Stream Facility (artificial rivers), a unique facility available at ICRA that will permit simultaneous study of biodegradation, photolysis, and adsorption /desorption processes under different situations, such as intermittent flow (drought), temperature or light fluctuations, among others. State of the art hybrid and high resolution mass spectrometric instrumentation will be used to study transformation pathways and provide a comprehensive and detailed profile of TPs formed. By using an integrated approach and simultaneous study of biotic and abiotic transformation processes TRANSFORMER’s main expected results are: (i) elucidation of transformation pathways (biological and photo induced) and identification of main TPs from a number of relevant pharmaceuticals (including some understudied and, for the first time, a new class pharmaceuticals such as peptidomimetics and peptide therapeutics); (ii) determination of partition coefficients (water-sediment and water-biofilm) of the studied pharmaceuticals and TPs and (iii) identification of potential controlling factors and mechanisms behind in-stream attenuation of pharmaceuticals (biodegradation vs photodegradation vs sorption). Accordingly, we expect that the results produced by this innovative research plan will have substantial impact on the field of inland water research, one of the Europe’s Societal Challenges.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine pharmacology and pharmacy pharmaceutical drugs
- natural sciences biological sciences biochemistry biomolecules
- natural sciences biological sciences ecology ecosystems
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF-EF-ST - Standard EF
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2014
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
17003 Girona
Spain
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.